{
  "cui": "C3658267",
  "cui_name": "Prostatic Neoplasms, Castration-Resistant",
  "incidence_per_100k": 3.2,
  "prevalence_per_100k": null,
  "metric_type": "incidence",
  "total_cases_per_year": 256000,
  "confidence": 0.68,
  "is_subtype": true,
  "parent_disease": "Prostate cancer",
  "reasoning": "Castration-resistant prostate cancer (CRPC) develops in ~10-15% of hormone-treated prostate cancer patients. Estimated ~3 per 100k men globally.",
  "data_quality": "moderate",
  "geographic_variation": "moderate",
  "year_specific": false,
  "data_year": 2005,
  "source": null,
  "source_url": null,
  "source_type": null
}
